| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 02/15/2001 | CA2378241A1 Benzanilides as potassium channel openers |
| 02/14/2001 | EP1075478A1 Phenylurea and phenylthio urea derivatives |
| 02/14/2001 | EP1075477A1 Novel n-oxides |
| 02/14/2001 | EP1075465A1 Arylphenyl-substituted cyclic keto enols |
| 02/14/2001 | EP0828714B1 Method for making quinolone carboxylic acids or naphthyridine carboxylic acids in free base form |
| 02/14/2001 | CN1284078A Heterocycilc compounds for inhibition of gastric acid secretion, processes for their prepn. and pharmaceutical compsns thereof |
| 02/14/2001 | CN1284077A Purine derivatives having phosphodiesterase IV inhibition activity |
| 02/14/2001 | CN1284075A Novel compounds having CGMP-PDE inhibitory effect |
| 02/14/2001 | CN1283995A Antiviral compounds |
| 02/14/2001 | CN1283623A 1,2,4,5-tetrahydro-benzo[d] azepine compound |
| 02/13/2001 | US6187928 Treating fungal diseases |
| 02/13/2001 | US6187786 Antitumor and anticarcinogenic agents |
| 02/13/2001 | US6187783 Antitumor agents |
| 02/13/2001 | US6187778 4-aminopyrrole (3, 2-D) pyrimidines as neuropeptide Y receptor antagonists |
| 02/13/2001 | US6187777 Pyrrolo(3,2-d)pyrimidine derivatives; neuropeptide y and corticotropin releasing factor modulators; dietetics; antidiabetic, antiinflammatory, and antitumor agents |
| 02/13/2001 | US6187776 Heterocyclic compounds and their use |
| 02/13/2001 | US6187775 Acridone-derived compounds useful as antineoplastic and antiretroviral agents |
| 02/13/2001 | US6187774 Fused heterocyclic compounds and pharmaceutical applications thereof |
| 02/13/2001 | US6187341 Trovafloxacin mesylate tablet |
| 02/13/2001 | CA2001203C Novel antimicrobial dithiocarbamoyl quinolones |
| 02/12/2001 | CA2280249A1 Vanadium compounds as anti-angiogenics and as inhibitors of endothelin production |
| 02/08/2001 | WO2001009138A2 Chemokine receptor antagonists and methods of use therefor |
| 02/08/2001 | WO2001009137A1 Chemokine receptor antagonists and methods of use therefor |
| 02/08/2001 | WO2001009133A1 NEW CYTOTOXIC PYRIDO[2,3,4-kl]ACRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE |
| 02/08/2001 | WO2001009132A1 C-6 RING-SUBSTITUTED PYRIDO[1,2-a]BENZIMIDAZOLE DERIVATIVES USEFUL IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS |
| 02/08/2001 | WO2001009131A1 Azaindolizinone derivatives and cerebral function improvers containing the same as the active ingredient |
| 02/08/2001 | WO2001009130A1 TRICYCLIC COMPOUNDS HAVING sPLA2-INHIBITORY ACTIVITIES |
| 02/08/2001 | WO2001009129A2 1h-pirido[3, 4-b]indol-1-one derivatives |
| 02/08/2001 | WO2001009121A2 2-pyrazolin-5-ones_as tyrosine kinase inhibitors |
| 02/08/2001 | WO2001009120A1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
| 02/08/2001 | WO2001009119A2 Chemokine receptor antagonists |
| 02/08/2001 | WO2001009094A2 Chemokine receptor antagonists and methods of use therefor |
| 02/08/2001 | WO2001009092A1 Biphenyl-substituted cyclic keto enols as pesticides |
| 02/08/2001 | WO2001008688A2 Beta-carboline drug products |
| 02/08/2001 | WO2001008663A2 Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs |
| 02/08/2001 | WO2000058307A3 Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands |
| 02/08/2001 | DE19937116A1 Moxifloxacin Kochsalzformulierung Moxifloxacin saline formulation |
| 02/08/2001 | CA2391766A1 C-6 ring-substituted pyrido¬1,2-a|benzimidazole derivatives usefu l in treating central nervous system disorders |
| 02/08/2001 | CA2391267A1 Chemokine receptor antagonists and methods of use therefor |
| 02/08/2001 | CA2380644A1 2-pyrazolin-5-ones |
| 02/08/2001 | CA2380582A1 New cytotoxic pyrido[2,3,4-kl]acridine derivatives, their preparation and their therapeutic use |
| 02/08/2001 | CA2380032A1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
| 02/08/2001 | CA2379660A1 Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs |
| 02/07/2001 | EP1074543A1 Aminopiperidine derivatives as integrin alpha v beta 3 antagonists |
| 02/07/2001 | EP1074257A1 2,7-Substituted octahydro-1H-pyrido (1,2-A)pyrazine derivatives as ligands for serotonin receptors |
| 02/07/2001 | EP1073657A1 Imidazo pyridine derivatives which inhibit gastric acid secretion |
| 02/07/2001 | EP1073656A1 Imidazo pyridine derivatives which inhibit gastric acid secretion |
| 02/07/2001 | EP1073655A1 Pharmaceutically available protoberberine salts derivatives, and protoberberine derivatives and salts thereof |
| 02/07/2001 | EP1073648A1 12,13-Modified epothilone derivatives |
| 02/07/2001 | EP0922035B1 Tetrahydroisoquinoline derivatives and their pharmaceutical use |
| 02/07/2001 | EP0799226B1 Tetracyclic spiro compounds, process for their preparation and their use as 5ht1d receptor antagonists |
| 02/07/2001 | CN1283197A Pleuromutilin derivatives as antimicrobials |
| 02/07/2001 | CN1283190A Substituted benzene compounds, process for their preparation and herbicidal and defoliant composition containing them |
| 02/07/2001 | CN1283186A Indole derivatives as XA factor inhibitors |
| 02/07/2001 | CN1282743A New beta-carbiline compounds, their preparation method and medicine composition conterning same |
| 02/07/2001 | CN1061658C Tricyclic benzazepine vasopression antagonists |
| 02/06/2001 | US6184389 Feature a plurality of functional groups attached to backbone and phosphoramidate sites |
| 02/06/2001 | US6184388 Antibacterial and antimicrobial, quinoline antibiotic |
| 02/06/2001 | US6184382 Process for preparing N6-substituted adenosine derivatives |
| 02/06/2001 | US6184380 Process for preparing naphthyridones and intermediates |
| 02/06/2001 | US6184378 Pigments, laser dyes and precursors for preparing fluorescent dyes, polymeric colorants, |
| 02/06/2001 | US6184237 Substituted pyridine compounds and methods of use |
| 02/06/2001 | US6184235 2-phenyl benzimidazole derivatives as MCP-1 antagonists |
| 02/06/2001 | US6184226 Antiinflammatory agents for treatment of cardiovascular system disorders/respiratory system disorders, antiischemic agents |
| 02/06/2001 | CA2314798A1 1,2,4,5-tetrahydro-benzo[d]azepin derivatives |
| 02/05/2001 | CA2314867A1 2,7-substituted octahydro-1h-pyrido¬1,2-a|pyrazine derivatives as ligands for serotonin receptors |
| 02/01/2001 | WO2001007436A2 Substituted oxoazaheterocyclyl compounds |
| 02/01/2001 | WO2001007432A2 Aminopiperidine derivatives as antibacterials |
| 02/01/2001 | WO2001007424A1 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands |
| 02/01/2001 | WO2001007406A1 Novel amide derivatives |
| 02/01/2001 | WO2001007052A1 Small molecules useful in the treatment of inflammatory disease |
| 02/01/2001 | WO2001007051A1 Prenyl-protein transferase inhibitors |
| 02/01/2001 | WO2001007050A1 Nociceptin receptor orl-1 agonists for use in treating cough |
| 02/01/2001 | WO2001007046A1 Prenyl-protein transferase inhibitors |
| 02/01/2001 | WO2001007045A1 Il-8 receptor antagonists |
| 02/01/2001 | WO2001006984A2 Small molecules useful in the treatment of inflammatory disease |
| 02/01/2001 | WO2000054764A3 A method of treating bulimia nervosa and related eating disorders by administration of atypical antipsychotic medications |
| 02/01/2001 | WO2000040226A3 Method of treating sexual disturbances |
| 02/01/2001 | WO2000038717A3 Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia |
| 02/01/2001 | WO2000037107A3 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia |
| 02/01/2001 | DE19935963A1 Biphenylsubstituierte cyclische Ketoenole Biphenyl-cyclic ketoenols |
| 02/01/2001 | CA2382755A1 Substituted oxoazaheterocyclyl compounds |
| 02/01/2001 | CA2379398A1 Nociceptin receptor orl-1 agonists for use in treating cough |
| 01/31/2001 | EP1071684A1 IMIDAZO 1,2-a]PYRIDINES AS PERIPHERAL BENZODIAZEPINE RECEPTOR BINDING AGENTS |
| 01/31/2001 | EP1071669A1 Bicyclic compounds having an anti-thrombitic effect |
| 01/31/2001 | EP1071666A1 Azacycloalkane derivatives, preparation and therapeutic application |
| 01/31/2001 | CN1282248A Combination effective for treatment of impotence |
| 01/31/2001 | CN1061351C Intermediates diaza or oxadiazabicyclic compounds |
| 01/31/2001 | CN1061349C Process for preparing loracarbff monohydrate |
| 01/31/2001 | CN1061348C New crystal modification of quinolinecarboxylic acid hydrochloride, process for its preparation and pharmaceutical formulations |
| 01/30/2001 | US6180647 Gastrointestinal disorders; nervous system disorders |
| 01/30/2001 | US6180643 Antagonist of interleukins, tumor necrosis factor |
| 01/30/2001 | US6180640 Di- and tetra-hydroquinoline-indole antimicrobial agents, uses and compositions related thereto |
| 01/30/2001 | US6180632 Use of these compounds for treating disorders/conditions involving cellular differentiation, proliferation, extracellular matrix production or mediator release and/or t cell activation and proliferation |
| 01/30/2001 | US6180631 Methods of modulating serine/threonine protein kinase function with 5-azaquinoxaline-based compounds |
| 01/30/2001 | US6180629 [4,5]-Fused-1,3-disubstituted-1,2-diazine-6-one derivatives with nitrogen containing substitutents in position one for the treatment of neoplasia |
| 01/25/2001 | WO2001005790A1 New compounds |
| 01/25/2001 | WO2001005789A1 TRICYCLIC COMPOUNDS HAVING sPLA2-INHIBITORY ACTIVITIES |
| 01/25/2001 | WO2001005772A1 Pyrazinones, compositions containing such compounds |
| 01/25/2001 | WO2001005770A1 Benzimidazolone derivatives and their use as phosphodiesterase inhibitors |